- Home
- PLRX vs UVE Comparison
PLRX vs UVE Comparison
Compare PLRX & UVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- UVE
- Stock Information
- Founded
- PLRX 2015
- UVE 1990
- Country
- PLRX United States
- UVE United States
- Employees
- PLRX N/A
- UVE N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- UVE Property-Casualty Insurers
- Sector
- PLRX Health Care
- UVE Finance
- Exchange
- PLRX Nasdaq
- UVE Nasdaq
- Market Cap
- PLRX 682.2M
- UVE 565.2M
- IPO Year
- PLRX 2020
- UVE 1992
- Fundamental
- Price
- PLRX $11.07
- UVE $19.54
- Analyst Decision
- PLRX Strong Buy
- UVE Buy
- Analyst Count
- PLRX 7
- UVE 1
- Target Price
- PLRX $40.50
- UVE $25.00
- AVG Volume (30 Days)
- PLRX 544.0K
- UVE 139.8K
- Earning Date
- PLRX 02-26-2025
- UVE 02-20-2025
- Dividend Yield
- PLRX N/A
- UVE 3.27%
- EPS Growth
- PLRX N/A
- UVE 4.62
- EPS
- PLRX N/A
- UVE 2.48
- Revenue
- PLRX N/A
- UVE $1,511,183,000.00
- Revenue This Year
- PLRX N/A
- UVE N/A
- Revenue Next Year
- PLRX N/A
- UVE N/A
- P/E Ratio
- PLRX N/A
- UVE $7.87
- Revenue Growth
- PLRX N/A
- UVE 12.23
- 52 Week Low
- PLRX $10.22
- UVE $15.78
- 52 Week High
- PLRX $18.92
- UVE $23.39
- Technical
- Relative Strength Index (RSI)
- PLRX 36.41
- UVE 38.75
- Support Level
- PLRX $10.94
- UVE $19.29
- Resistance Level
- PLRX $12.70
- UVE $19.80
- Average True Range (ATR)
- PLRX 0.77
- UVE 0.52
- MACD
- PLRX -0.18
- UVE -0.01
- Stochastic Oscillator
- PLRX 4.69
- UVE 32.67
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About UVE UNIVERSAL INSURANCE HOLDINGS INC
Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums. It operates within Florida and across the United States. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.